Nature Communications (Jul 2019)

ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy

  • Yuan Tian,
  • Bin Yang,
  • Weinan Qiu,
  • Yajing Hao,
  • Zhenxing Zhang,
  • Bo Yang,
  • Nan Li,
  • Shuqun Cheng,
  • Zhangjun Lin,
  • Yao-cheng Rui,
  • Otto K. W. Cheung,
  • Weiqin Yang,
  • William K. K. Wu,
  • Yue-Sun Cheung,
  • Paul B. S. Lai,
  • Jianjun Luo,
  • Joseph J. Y. Sung,
  • Runsheng Chen,
  • Hong-Yang Wang,
  • Alfred S. L. Cheng,
  • Pengyuan Yang

DOI
https://doi.org/10.1038/s41467-019-11274-x
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 16

Abstract

Read online

Non alcoholic fatty liver disease (NAFLD) associates with an elevated risk of developing hepatocellular carcinoma (HCC). Here, the authors find that Nogo-B, an endoplasmic reticulum resident protein, is upregulated by lipid uptake and acts as an oncogene in NAFLD-associated HCC by promoting lipid droplet breakdown by lipophagy and triggering Hippo pathway dysregulation